FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

24869004: Nifurtimox (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
41680013 Nifurtimox en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2147936013 Nifurtimox (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nifurtimox Is a Antitrypanosomal drug false Inferred relationship Some
Nifurtimox Is a Substance with antitrypanosomal mechanism of action false Inferred relationship Some
Nifurtimox Is a Nitrofuran derivative true Inferred relationship Some
Nifurtimox This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antitrypanosomal false Inferred relationship Some
Nifurtimox Is a Antiprotozoal true Inferred relationship Some
Nifurtimox This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) false Inferred relationship Some
Nifurtimox This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antiprotozoal true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing nifurtimox (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nifurtimox Inferred relationship Some 1
Nifurtimox-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nifurtimox Inferred relationship Some 1
Product containing only nifurtimox (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nifurtimox Inferred relationship Some 1
Product containing only nifurtimox in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nifurtimox Inferred relationship Some 1
Nifurtimox 30 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nifurtimox Inferred relationship Some 1
Nifurtimox 30 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nifurtimox Inferred relationship Some 1
Product containing precisely nifurtimox 120 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nifurtimox Inferred relationship Some 1
Product containing precisely nifurtimox 120 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nifurtimox Inferred relationship Some 1

This concept is not in any reference sets

Back to Start